Krebs Biochemicals & Industries Limited (BSE: 524518)
Health Care · Pharmaceuticals · IN
Rs55.72
-19.71% today · -22.8% 1Y
Krebs Biochemicals & Industries Limited (BSE: 524518) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.41M.
Over the last twelve months the share price has lost 22.8%, trading between 38.52 and 76.72.
Tweenvest scores Krebs Biochemicals & Industries Limited across four factors: quality 29/100, value 63/100, growth 0/100. Its strongest factor is value.
524518 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.41M
- Revenue (TTM)
- $2.67M
- P/E
- —
- EPS
- -6.53
- Dividend yield
- —
- Beta (5Y)
- 0.90
- 52-week high
- Rs76.72
- 52-week low
- Rs38.52
- Avg volume (3M)
- —
- Shares outstanding
- 21.56M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.90 | +0.51% |
| Liven Pharma LimitedKASE: LIVEN | $12.40M | PKRs30.37 | -2.47% |
| Alpa Laboratories LimitedNSEI: ALPA | $12.39M | Rs56.99 | -3.83% |
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $— | — |
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $11.84M | ₩2,570.00 | -3.20% |
Figures last refreshed Oct 11, 2026.